We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ADVANTECH SERVICE-IOT CO., LTD. TAIWAN BRAN

Download Mobile App




Image: The Siemens Healthineers Total Antibody COV2T assay (Photo courtesy of Siemens Healthineers)

Siemens Granted FDA Emergency Use Authorization for SARS-CoV-2 Total Antibody Test

Siemens Healthineers (Erlangen, Germany) has secured Emergency Use Authorization from the US Food and Drug Administration for its laboratory-based total antibody test to detect the presence of SARS-CoV-2 antibodies, including IgM and IgG in blood. More...
02 Jun 2020
Illustration

Gilead’s Phase 3 Trial of Remdesivir Demonstrates Significantly Greater Clinical Improvement in Patients with Moderate COVID-19

Gilead Sciences, Inc. (Foster City, CA, USA) has announced topline results from the Phase 3 SIMPLE trial in hospitalized patients with moderate COVID-19 pneumonia. More...
02 Jun 2020
Radcal
Image: PrimeStore Molecular Transport Medium (Photo courtesy of Longhorn Vaccines and Diagnostics LLC)

Longhorn Vaccines and Cenetron Diagnostics Join Coca-Cola Bottlers to Produce COVID-19 Test Kits

Longhorn Vaccines and Diagnostics LLC (Bethesda, MD, USA) and Cenetron Diagnostics (Austin, TX, USA) have collaborated with Southeastern Container (SEC) to expand production of COVID-19 testing kits. More...
02 Jun 2020
Image: Eli Lilly and AbCellera Begin World`s First Study of Potential COVID-19 Antibody Treatment in Humans (Photo courtesy of Eli Lilly and Company)

Eli Lilly and AbCellera Begin World's First Study of Potential COVID-19 Antibody Treatment in Humans

Eli Lilly and Company (Indianapolis, Ind, USA) has begun dosing patients in the world's first study of a potential antibody treatment designed to fight COVID-19. More...
02 Jun 2020
Image: Celltrion’s COVID- 19 Antiviral Antibody Treatment Shows Improved Recovery Time in Pre-Clinical Study (Photo courtesy of Celltrion Group)

Celltrion’s COVID- 19 Antiviral Antibody Treatment Shows Improved Recovery Time in Pre-Clinical Study

Celltrion Group (Incheon, South Korea) has announced positive pre-clinical results for its COVID-19 antiviral antibody treatment, with data demonstrating a 100-fold reduction in the viral load of SARS-CoV-2. More...
02 Jun 2020
Illustration

COVID-19 Vaccine Likely to Be Ready by October This Year, Says Pfizer CEO

A COVID-19 vaccine could be ready by the end of this year, according to Albert Bourla, head Pfizer Inc. (New York, NY, USA) which is conducting clinical trials of vaccines against the novel coronavirus. More...
01 Jun 2020
Illustration

New Technology Solutions Use Real Time, Scientific, and Geocoded Data to `Flatten the COVID-19 Curve`

Two new technology solutions will enable Americans to "Flatten the COVID-19 Curve" using real time, scientific, and geocoded data generated from social media, public, and private organizations. More...
01 Jun 2020
Copyright © 2000-2020 Globetech Media. All rights reserved.